Results 291 to 300 of about 498,550 (314)

Hyperprogressive disease during PD-1/PD-L1 blockade in patients with non-small-cell lung cancer

Annals of Oncology, 2019
C G Kim, S J Choi, H I Yoon
exaly  

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Annals of Oncology, 2019
H A Yu, Jungmin Choi, H Rizvi
exaly  

PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer

Proceedings of the National Academy of Sciences of the United States of America, 2019
Takahiro Kamada, Yosuke Togashi, Akinori Sasaki   +2 more
exaly  

THE BLOCKADE

2021
openaire   +1 more source

Blockades

2003
openaire   +1 more source

Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors

Cancer Cell, 2019
Rachel Grosser, Leonid Cherkassky, Navin K Chintala   +2 more
exaly  

Blockades

2018
openaire   +1 more source

The Blockade

Scientific American
openaire   +2 more sources

Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

Cell, 2019
Joseph L Benci, Ruth Choa, Yuanming Xu
exaly  

The Blockade

2019
openaire   +2 more sources